Transforming data into cures

Data science is at the core of today’s most innovative cancer research, and MSK is uniquely situated to lead the cancer data revolution. Equipped with high-quality genomic and imaging samples from over 100,000 patients, MSK experts are using data science and AI to improve cancer care and outcomes worldwide.

Support data science endeavors

Dr. Sohrab Shah, Chief of Computational Oncology in the Department of Epidemiology and Biostatistics, speaks to an MSK staff member who is sitting in front of a computer monitor displaying an image of cells.

Expanding our understanding of troves of cancer data today

Our Computational Oncology program applies computer science, data engineering, machine learning, and software tools to advance care.
SKI’s Computational and Systems Biology Program combines biological findings with computer algorithms and databases for research.
Computational biology fellowships and undergraduate programs train young scientists.

So more people with cancer can live longer lives tomorrow

As we expand data collection and computational abilities, we are on the brink of even more discoveries that can improve cancer care for people worldwide. Understanding how cancer develops is the first step toward new preventative strategies, treatments, and cures. Your support ensures this research will continue and potentially save lives.

MSK innovations save lives

MSK’s Dr. Veronica Rotemberg and Dr. Alina Markova in clinic with a patient.

MSK dermatologists Veronica Rotemberg, MD, PhD, (left) and Alina Markova, MD, are using artificial intelligence and other leading-edge technologies to transform skin cancer detection and treatment.

Watch the video to learn more

Dr. Sohrab Shah, standing in front of a white board with graphs on it and smiling.

Sohrab Shah, PhD, Nicholls-Biondi Chair and MSK’s first Chief of Computational Oncology, leads our work dedicated to harnessing MSK’s numerous big data resources and translating biologic knowledge into better patient care. 

Dana Pe’er, PhD, Alan and Sandra Gerry Endowed Chair and Chair of the Computational and Systems Biology Program, says, “What sets MSK apart is the ability for computational and cancer experts to work together as partners.”

Learn more about her work

Three MSK staff members stand in a lab, looking at a computer monitor.

MSK researchers used computational methods to develop MSK-IMPACT®, which can detect more than 500 genes for cancer mutations and help match patients with treatments that target the molecules driving the growth of their cancers.

Surgeon-scientist Luc Morris, MD, MSc, is leading research at MSK that is testing whether an artificial intelligence-based model called SCORPIO can better predict how people will respond to certain immunotherapy drugs.

Transforming cancer care

Computational biology and artificial intelligence are playing increasingly important roles in cancer research and care. Generous support from across the MSK Giving community is driving new breakthroughs and discoveries in these fields.

A gift from the Halvorsen Family Foundation is strengthening MSK’s computational oncology initiatives through the Diane and Andreas Halvorsen Center for Computational Oncology Research and two Halvorsen Fellowships.

Learn how donors help

Propelling pathology

AI helps doctors interpret digital images and slides to diagnose cancer and track its progression. A gift from the Warren Alpert Foundation positioned MSK as a major hub for digital imaging and computational pathology. 

Learn about computational pathology

Building new tools

A team of MSK researchers developed a new open-source computational method called Spectra to more effectively analyze data at the single-cell level.

Learn about the technology

Help us decipher clues in vast volumes of cancer data

Make a gift

Donate to MSK to fund life-changing research and care.

Donate now

Start a fundraiser

Invite your friends and family to join you in your mission.

Get started

Attend an event

Come to a fundraising event to show your support.

Browse events

To discover more ways to partner in our work, email us.

development@mskcc.org

An MSK clinician smiles as she holds a stethoscope to a patient’s chest.

The MSK Campaign: Leading Science. Changing Lives.

The MSK community is raising $6 billion by 2030 to accelerate advances across six key strategic initiatives. Learn more and join us in our mission of ending cancer for life.

Learn more about The MSK Campaign

Innovating in care delivery Pioneering discovery science Harnessing the immune system Expanding precision oncology Developing the new generation of leaders